Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hangeshashinto for prevention of severe pharyngeal mucositis during radiotherapy
jRCTs071200010Completed
- Start
- Aug 2020
- Countries
- 1
01
Overview
Open-label trial of Banxia Xiexin Decoction in mucositis, hypopharyngeal cancer and laryngeal cancer (2 arms). Primary endpoint: Incident and radiation dose at onset of grade 2 pharyngeal mucositis. Started Aug 2020; status: completed.
02
Drugs
Banxia Xiexin Decoction
03
Conditions
mucositishypopharyngeal cancerlaryngeal cancer
Beyond the preview
Go deeper on jRCTs071200010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071200010.